UnitedHealth Group Incorporated (UNH) Stock Analysis
Latest ClaritX AI analysis ·
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease mana
| Metric | Value |
|---|---|
| Price | $376.32 |
| Market cap | $341.8B |
| Sector | Healthcare |
| Industry | Medical - Healthcare Plans |
| ClaritX AI score | 88/100 |
| Price/Book | 3.46 |
| Dividend yield | 2.41% |
| Beta | 0.62 |
AI verdict
UnitedHealth Group (UNH) currently presents a highly compelling, albeit increasingly complex, defensive value proposition for institutional investors. Trading at $376.32, the equity remains entrenched at an 18.5% discount from its 52-week high of $461.62. In a macroeconomic environment fraught with rotational volatility, acquiring a monopolistic healthcare conglomerate at this substantial markdown offers a massive intrinsic margin of safety. This downside protection is mathematically cemented by the stock's ultra-low beta of 0.622, ensuring UNH absorbs nearly 40% less systemic volatility than the broader benchmark indices, acting as a premier portfolio stabilizer. Despite emerging headline friction—including a newly launched Texas AG probe and a prominent sell-side downgrade citing realized margin recoveries—the underlying financial fortress remains totally intact. UNH generates an immense $26.06 in free cash flow per share and trades at a deeply compressed Price-to-Sales multiple of 0.76. Supported by an incredibly secure $9.06 annualized dividend and massive institutional price targets hovering near $488, the stock offers a highly asymmetric risk-reward profile. As the market pivots toward the October 13 earnings catalyst, UNH stands out as an elite, cash-flowing defensive anchor. Rating 88/100
What this score has been worth
ClaritX scores UNH 88 out of 100 (snapshot 2026-10-06).
Every ClaritX analysis is scored first and judged only on what the stock did afterwards. Across the 203 analyses that scored in the 85-89 band, the average forward return was +2.0% with a 53% win rate, -4.0pp against the S&P 500. That is a measured tendency across many names, not a forecast for UNH — roughly 47% of stocks in this band still lost money.
The full band-by-band table, including the bands that lost, is on the AI Rank Report; the live strategy arms behind it are on the AI Track Record, losses published.